InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Leaman John Harold. Director active across 2 companies, notably IMPEL PHARMACEUTICALS INC. Cumulatively, 2 filings have been recorded. Activity tracked since 31 December 2022. The latest transaction was filed on 12 December 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations